fda stops semaglutide Compound versions of GLP-1 drugs for weight loss halted by Compound versions of GLP-1 drugs
Description
Weight loss medications like semaglutides are on the rise, and we have answers on how they affect fertility.
This study compares GLP-1 analogs to dipeptidyl peptidase 4 inhibitors (DPP4i) regarding thromboembolic events in RA
No nausea
Researchers assess whether GLP-1 receptor agonists increase the risk of suicide, self-harm, or suicidal ideation in type 2 diabetes patients.
Make an informed decision for your weight loss journey.
HR, 0.94
